Rosuvastatin versus placebo for delirium in intensive care and subsequent cognitive impairment in patients with sepsis-associated acute respiratory distress syndrome: An ancillary study to a randomised controlled trial

The Lancet Respiratory Medicine

Volumn 4, Issue 3, 2016, Pages 203-212

  Needham, Dale M ^a,c   Colantuoni, Elizabeth ^a,b   Dinglas, Victor D ^a,c   Hough, Catherine L ^d   Wozniak, Amy W ^a,b   Jackson, James C ^e   Morris, Peter E ^f   Mendez Tellez, Pedro A ^a,c   Ely, E Wesley ^e,g   Hopkins, Ramona O ^h,i,j  

^a JOHNS HOPKINS UNIVERSITY   (United States)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF WASHINGTON   (United States)

^e VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f UNIVERSITY OF KENTUCKY   (United States)

^g VETERANS AFFAIRS MEDICAL CENTER   (United States)

^h INTERMOUNTAIN MEDICAL CENTER   (United States)

ⁱ BRIGHAM YOUNG UNIVERSITY   (United States)

^j INTERMOUNTAIN HEALTHCARE   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

PLACEBO; ROSUVASTATIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ADULT; ADULT RESPIRATORY DISTRESS SYNDROME; ARTICLE; COGNITION; COGNITIVE DEFECT; CONFUSION; CONTROLLED STUDY; CRITICALLY ILL PATIENT; DELIRIUM; DOUBLE BLIND PROCEDURE; FEMALE; HUMAN; INTENSIVE CARE; INTENTION TO TREAT ANALYSIS; LOADING DRUG DOSE; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTICENTER STUDY; OBSERVATIONAL STUDY; PLEIOTROPY; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; SEPSIS ASSOCIATED ACUTE RESPIRATORY DISTRESS SYNDROME; ADVERSE EFFECTS; AGED; ARTIFICIAL VENTILATION; CLINICAL TRIAL; COGNITIVE DYSFUNCTION; COMPLICATION; CONCEPT FORMATION; LANGUAGE DISORDERS; MEMORY; MIDDLE AGED; RESPIRATORY DISTRESS SYNDROME, ADULT; SEPSIS; TIME FACTOR;

ADULT; AGED; COGNITIVE DYSFUNCTION; CONCEPT FORMATION; DELIRIUM; DOUBLE-BLIND METHOD; FEMALE; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; LANGUAGE DISORDERS; MALE; MEMORY; MIDDLE AGED; RESPIRATION, ARTIFICIAL; RESPIRATORY DISTRESS SYNDROME, ADULT; ROSUVASTATIN CALCIUM; SEPSIS; TIME FACTORS;

EID: 84959514661     PISSN: 22132600     EISSN: 22132619     Source Type: Journal    
DOI: 10.1016/S2213-2600(16)00005-9     Document Type: Article

References (63)

1. Pandharipande PP, Girard TD, Jackson JC, et al. Long-term cognitive impairment after critical illness. N Engl J Med 2013, 369:1306-1316.
2. Milbrandt EB, Deppen S, Harrison PL, et al. Costs associated with delirium in mechanically ventilated patients. Crit Care Med 2004, 32:955-962.
3. Eeles EM, Hubbard RE, White SV, O'Mahony MS, Savva GM, Bayer AJ Hospital use, institutionalisation and mortality associated with delirium. Age Ageing 2010, 39:470-475.
4. Barr J, Fraser GL, Puntillo K, et al. Clinical practice guidelines for the management of pain, agitation, and delirium in adult patients in the intensive care unit. Crit Care Med 2013, 41:263-306.
5. Semmler A, Okulla T, Sastre M, Dumitrescu-Ozimek L, Heneka MT Systemic inflammation induces apoptosis with variable vulnerability of different brain regions. J Chem Neuroanat 2005, 30:144-157.
6. Girard TD, Ware LB, Bernard GR, et al. Associations of markers of inflammation and coagulation with delirium during critical illness. Intensive Care Med 2012, 38:1965-1973.
7. Cerejeira J, Firmino H, Vaz-Serra A, Mukaetova-Ladinska EB The neuroinflammatory hypothesis of delirium. Acta Neuropathol 2010, 119:737-754.
8. Morandi A, Hughes CG, Girard TD, McAuley DF, Ely EW, Pandharipande PP Statins and brain dysfunction: a hypothesis to reduce the burden of cognitive impairment in patients who are critically ill. Chest 2011, 140:580-585.
9. Papadopoulos MC, Lamb FJ, Moss RF, Davies DC, Tighe D, Bennett ED Faecal peritonitis causes oedema and neuronal injury in pig cerebral cortex. Clin Sci (Lond) 1999, 96:461-466.
10. McGown CC, Brown NJ, Hellewell PG, Reilly CS, Brookes ZL Beneficial microvascular and anti-inflammatory effects of pravastatin during sepsis involve nitric oxide synthase III. Br J Anaesth 2010, 104:183-190.
11. Dichtl W, Dulak J, Frick M, et al. HMG-CoA reductase inhibitors regulate inflammatory transcription factors in human endothelial and vascular smooth muscle cells. Arterioscler Thromb Vasc Biol 2003, 23:58-63.
12. Terblanche M, Almog Y, Rosenson RS, Smith TS, Hackam DG Statins and sepsis: multiple modifications at multiple levels. Lancet Infect Dis 2007, 7:358-368.
13. Ostadal P, Alan D, Hajek P, et al. The effect of early treatment by cerivastatin on the serum level of C-reactive protein, interleukin-6, and interleukin-8 in the patients with unstable angina and non-Q-wave myocardial infarction. Mol Cell Biochem 2003, 246:45-50.
14. Shyamsundar M, McKeown ST, O'Kane CM, et al. Simvastatin decreases lipopolysaccharide-induced pulmonary inflammation in healthy volunteers. Am J Respir Crit Care Med 2009, 179:1107-1114.
15. Wang H, Lynch JR, Song P, et al. Simvastatin and atorvastatin improve behavioral outcome, reduce hippocampal degeneration, and improve cerebral blood flow after experimental traumatic brain injury. Exp Neurol 2007, 206:59-69.
16. Alexandre PCB, Reis PA, D'Avila J, et al. Atorvastatin and simvastatin protects cognitive impairment in an animal model of sepsis. Crit Care 2013, 17(suppl 4):57-58.
17. Katznelson R, Djaiani GN, Borger MA, et al. Preoperative use of statins is associated with reduced early delirium rates after cardiac surgery. Anesthesiology 2009, 110:67-73.
18. Katznelson R, Djaiani G, Mitsakakis N, et al. Delirium following vascular surgery: increased incidence with preoperative beta-blocker administration. Can J Anaesth 2009, 56:793-801.
19. Morandi A, Hughes CG, Thompson JL, et al. Statins and delirium during critical illness: a multicenter, prospective cohort study. Crit Care Med 2014, 42:1899-1909.
20. Page VJ, Davis D, Zhao XB, et al. Statin use and risk of delirium in the critically ill. Am J Respir Crit Care Med 2014, 189:666-673.
21. Casarin A, McAuley DF, Alce TM, et al. Evaluating early administration of the hydroxymethylglutaryl-CoA reductase inhibitor simvastatin in the prevention and treatment of delirium in critically ill ventilated patients (MoDUS trial): study protocol for a randomized controlled trial. Trials 2015, 16:218.
22. Taburyanskaya M, Hassig T Statins and delirium: is there a role?. Curr Atheroscler Rep 2015, 17:470.
23. Truwit JD, Bernard GR, Steingrub J, et al. Rosuvastatin for sepsis-associated acute respiratory distress syndrome. N Engl J Med 2014, 370:2191-2200.
24. Morandi A, Pandharipande PP, Shintani AK, et al. Statin use and the daily risk of delirium in a prospective cohort of critically ill patients. Am J Respir Crit Care Med 2012, 185:A3646.
25. Rice TW, Wheeler AP, Thompson BT, et al. Initial trophic vs full enteral feeding in patients with acute lung injury: the EDEN randomized trial. JAMA 2012, 307:795-803.
26. Needham DM, Dinglas VD, Morris PE, et al. Physical and cognitive performance of patients with acute lung injury 1 year after initial trophic versus full enteral feeding. EDEN trial follow-up. Am J Respir Crit Care Med 2013, 188:567-576.
27. Brower RG, Matthay MA, Morris A, Schoenfeld D, Thompson BT, Wheeler A Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. The Acute Respiratory Distress Syndrome Network. N Engl J Med 2000, 342:1301-1308.
28. Wiedemann HP, Wheeler AP, Bernard GR, et al. Comparison of two fluid-management strategies in acute lung injury. N Engl J Med 2006, 354:2564-2575.
29. Robinson KA, Dennison CR, Wayman DM, Pronovost PJ, Needham DM Systematic review identifies number of strategies important for retaining study participants. J Clin Epidemiol 2007, 60:757-765.
30. Tansey CM, Matte AL, Needham D, Herridge MS Review of retention strategies in longitudinal studies and application to follow-up of ICU survivors. Intensive Care Med 2007, 33:2051-2057.
31. Hall EA, Zuniga R, Cartier J, et al. Staying in touch: a fieldwork manual of tracking procedures for locating substance abusers in follow-up studies 2003, UCLA Integrated Substance Abuse Programs, Los Angeles, CA. second edition.
32. Roary MC, Hill MN, Bone LR, Levine DM Innovative strategies that dispel the myths about urban young black men with high blood pressure. Cardiovasc Rev Rep 2000, 21:129-137.
33. Coday M, Boutin-Foster C, Goldman ST, et al. Strategies for retaining study participants in behavioral intervention trials: retention experiences of the NIH Behavior Change Consortium. Ann Behav Med 2005, 29(suppl):55-65.
34. Hunt JR, White E Retaining and tracking cohort study members. Epidemiol Rev 1998, 20:57-70.
35. Robinson KA, Dinglas VD, Sukrithan V, et al. Updated systematic review identifies substantial number of retention strategies: using more strategies retains more study participants. J Clin Epidemiol 2015, 68:1481-1487.
36. Ely EW, Inouye SK, Bernard GR, et al. Delirium in mechanically ventilated patients: validity and reliability of the confusion assessment method for the intensive care unit (CAM-ICU). JAMA 2001, 286:2703-2710.
37. Pun BT, Gordon SM, Peterson JF, et al. Large-scale implementation of sedation and delirium monitoring in the intensive care unit: a report from two medical centers. Crit Care Med 2005, 33:1199-1205.
38. Vasilevskis EE, Morandi A, Boehm L, et al. Delirium and sedation recognition using validated instruments: reliability of bedside intensive care unit nursing assessments from 2007 to 2010. J Am Geriatr Soc 2011, 59(suppl 2):S249-S255.
39. Ely EW, Truman B, Shintani A, et al. Monitoring sedation status over time in ICU patients: reliability and validity of the Richmond Agitation-Sedation Scale (RASS). JAMA 2003, 289:2983-2991.
40. Christie JD, Biester RC, Taichman DB, et al. Formation and validation of a telephone battery to assess cognitive function in acute respiratory distress syndrome survivors. J Crit Care 2006, 21:125-132.
41. Hopkins RO, Weaver LK, Collingridge D, Parkinson RB, Chan KJ, Orme JF Two-year cognitive, emotional, and quality-of-life outcomes in acute respiratory distress syndrome. Am J Respir Crit Care Med 2005, 171:340-347.
42. Burgess PW, Shallice T The Hayling and Brixton Tests 2007, Thames Valley Test Company Limited, London, England.
43. Lezak MD Neuropsychological Assessment 1995, Oxford University Press, New York. Third edn.
44. Wechsler D Wechsler Memory Scale 1997, The Psychology Corporation, San Antonio. Third edn.
45. Heaton RK, Miller SW, Taylor JR, Grant I Comprehensive norms for an expanded Halstead-Reitan battery: demographically adjusted neuropsychological norms for African American and Caucasian Adults. Professional Manual 2004, Psychological Assessment Resources, Lutz, Florida.
46. Rondeau V, Mathoulin-Pelissier S, Jacqmin-Gadda H, Brouste V, Soubeyran P Joint frailty models for recurring events and death using maximum penalized likelihood estimation: application on cancer events. Biostatistics 2007, 8:708-721.
47. Wassenaar A, van den Boogaard M, van AT, et al. Multinational development and validation of an early prediction model for delirium in ICU patients. Intensive Care Med 2015, 41:1048-1056.
48. Zaal IJ, Devlin JW, Peelen LM, Slooter AJ A systematic review of risk factors for delirium in the ICU. Crit Care Med 2015, 43:40-47.
49. Rondeau V, Mazroui Y, Gonzalez JR Frailtypack: an R package for the analysis of correlated survival data with frailty models using penalized likelihood estimation or parametric estimation. J Stat Softw 2012, 47:1-28.
50. Steiger JH, Fouladi RT Noncentrality interval estimation and the evaluation of statistical models. What if there were no significance tests? 1997, 221-258. Erlbaum, Mahwah, NJ. L.L. Harlow, S.A. Mulaik, J.H. Steiger (Eds.).
51. Hedges LV, Olkin I Statistical methods for meta-analysis 1985, Academic Press, San Diego, CA.
52. Salluh JI, Wang H, Schneider EB, et al. Outcome of delirium in critically ill patients: systematic review and meta-analysis. BMJ 2015, 350:h2538.
53. Tleyjeh IM, Kashour T, Hakim FA, et al. Statins for the prevention and treatment of infections: a systematic review and meta-analysis. Arch Intern Med 2009, 169:1658-1667.
54. Janda S, Young A, Fitzgerald JM, Etminan M, Swiston J The effect of statins on mortality from severe infections and sepsis: a systematic review and meta-analysis. J Crit Care 2010, 25:656-722.
55. Khan AR, Riaz M, Bin Abdulhak AA, et al. The role of statins in prevention and treatment of community acquired pneumonia: a systematic review and meta-analysis. PLoS One 2013, 8:e52929.
56. Furlow B Might statins prevent delirium in intensive care units?. Lancet Respir Med 2014, 2:180.
57. Lee KT, Lai WT, Chu CS, et al. Effect of withdrawal of statin on C-reactive protein. Cardiology 2004, 102:166-170.
58. van der Harst P, Asselbergs FW, Hillege HL, et al. Effect of withdrawal of pravastatin therapy on C-reactive protein and low-density lipoprotein cholesterol. Am J Cardiol 2007, 100:1548-1551.
59. Williamson PR, Altman DG, Blazeby JM, et al. Developing core outcome sets for clinical trials: issues to consider. Trials 2012, 13:132.
60. Masadeh M, Mhaidat N, Alzoubi K, Al-Azzam S, Alnasser Z Antibacterial activity of statins: a comparative study of atorvastatin, simvastatin, and rosuvastatin. Ann Clin Microbiol Antimicrob 2012, 11:13.
61. McAuley DF, Laffey JG, O'Kane CM, et al. Simvastatin in the acute respiratory distress syndrome. N Engl J Med 2014, 371:1695-1703.
62. Jackson JC, Hart RP, Gordon SM, et al. Six-month neuropsychological outcome of medical intensive care unit patients. Crit Care Med 2003, 31:1226-1234.
63. Hoenig JM, Heisey DM The abuse of power: the pervasive fallacy of power calculations for data analysis. Am Stat 2008, 55:19-24.